CIK 0001788028 · <br>Emerging growth company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842984849
- Phone
- 6505491400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-21 | Lis William See Remarks | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-03-21 | French Anna Louise Director | Grant or award · Stock Option (right to buy) | +78,045 | 78,045 | ||
| 2022-03-21 | Abingworth LLP 10% owner | Grant or award · Stock Option (right to buy) | +78,045 | 78,045 | ||
| 2021-09-24 | Clifford Kenneth F FORMER OFFICER | Option exercise | +2,300,000 | 2,300,000 | ||
| 2021-09-24 | Clifford Kenneth F FORMER OFFICER | Returned to the company · Class B Common Stock | +200,000 | 0 | ||
| 2021-09-24 | Clifford Kenneth F FORMER OFFICER | Option exercise · Class B Common Stock | +2,300,000 | 0 | ||
| 2021-09-24 | HOFFEN HOWARD I FORMER DIRECTOR | Option exercise | +2,300,000 | 2,300,000 | ||
| 2021-09-24 | HOFFEN HOWARD I FORMER DIRECTOR | Returned to the company · Class B Common Stock | +200,000 | 0 | ||
| 2021-09-24 | HOFFEN HOWARD I FORMER DIRECTOR | Option exercise · Class B Common Stock | +2,300,000 | 0 |
Page 7 of 7 · 129 trades